NCT02353494View on ClinicalTrials.gov

Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria

CompletedOBSERVATIONAL
Enrollment

130

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Plasmodium Falciparum InfectionPlasmodium Vivax Infection
Interventions
DRUG

Dihydroartemisinin-Piperaquine

Treatment according to national guidelines with follow up.

Trial Locations (1)

Unknown

Timika District Hospital, Timika

All Listed Sponsors
collaborator

Eijkman Institute for Molecular Biology

OTHER

collaborator

World Health Organization

OTHER

lead

Menzies School of Health Research

OTHER

NCT02353494 - Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria | Biotech Hunter | Biotech Hunter